The numbers don't lie. AndrexXa is not on it's way to be a blockbuster. While I am sure COVID had an impact, the last qtr marked 3 straight qtrs of declining sales. After the disappointing 2019 4th qtr numbers, I asked is this a blip or a trend? We now have that answer.
Truth is, we were lucky to get $18 per share, AXLN bailed our assess out. Without that buyout we would have been in the low single digits.
Again, I would like to thank you all for the lessons learned, which were many, and I was able to take away some great friends through my investment in PTLA. I know we all wish it turned out differently, it didn't and now on to the next, hopefully with better results.